Skip to content

SCIENCE ET MEDECINE: what changed

BE 0451.433.347NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€34,752
2024 · -€11,540-€23,212
Equity
€91,996
2024 · €201,748-€109,752
Cash
€75,508
2024 · €148,803-€73,295
Balance sheet total
€127,922
2024 · €283,932-€156,010

Largest movements

2024 to 2025
Assets
  • Cash -€73,295

    down €73,295 (-49.3%), from €148,803 to €75,508

    mainly Contributions, distributions and other (-€75,000) and Net result for the year (-€34,752)

  • Receivables within one year -€50,125

    down €50,125 (-88.6%), from €56,604 to €6,479

    of which Trade receivables: -€54,116

  • Intangible fixed assets -€22,865

    no longer reported in 2025 (was €22,865)

  • Tangible fixed assets -€10,351

    down €10,351 (-23.4%), from €44,280 to €33,930

    of which Furniture and vehicles: -€9,327

Equity and liabilities
  • Profit (loss) carried forward -€106,298

    no longer reported in 2025 (was €106,298)

  • Trade debts -€34,619

    down €34,619 (-88.7%), from €39,042 to €4,424

  • Debts after one year -€7,603

    down €7,603 (-24.4%), from €31,141 to €23,538

  • Reserves -€5,404

    down €5,404 (-7.1%), from €75,950 to €70,546

    of which Distributable reserves: -€3,454

  • Other debts -€4,327

    down €4,327 (-95.4%), from €4,535 to €208

Income statement
  • Purchases and services -€50,583

    no longer reported in 2025 (was €50,583)

  • Turnover -€33,657

    no longer reported in 2025 (was €33,657)

  • Taxes -€5,414

    down €5,414, from €678 to -€4,736

  • Other operating charges +€2,998

    up €2,998 (+255%), from €1,178 to €4,176

  • Gross operating margin +€1,474

    up €1,474 (+115%), from €1,277 to €2,751

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€11,540
Gross operating margin +€1,474
Depreciation -€188
Other operating charges -€2,998
Other operating items -€27,867
Financial income +€615
Financial charges +€340
Taxes +€5,414
Result 2025 -€34,752
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€14,898
Investment +€23,980
Financing -€82,377
Cash 2024 €148,803
Net result for the year -€34,752
Depreciation +€9,235
Stocks and contracts +€2,188
Receivables within one year +€50,125
Deferred charges and accrued income -€2,813
Trade debts -€34,619
Smaller working-capital items +€64
Other debts -€4,327
Investment in fixed assets (net) +€23,980
Debts after one year -€7,603
Current portion of long-term debt +€227
Contributions, distributions and other -€75,000
Cash 2025 €75,508
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €283,932 €127,922 -€156,010 -54.9%
Fixed assets 21/28 €68,047 €34,832 -€33,215 -48.8%
Intangible fixed assets 21 €22,865 - -€22,865
Tangible fixed assets 22/27 €44,280 €33,930 -€10,351 -23.4%
Land and buildings 22 €4,403 €3,379 -€1,024 -23.3%
Plant, machinery and equipment 23 €0 - =
Furniture and vehicles 24 €39,877 €30,550 -€9,327 -23.4%
Financial fixed assets 28 €902 €902 = 0.0%
Current assets 29/58 €215,885 €93,090 -€122,795 -56.9%
Stocks and contracts in progress 3 €10,477 €8,290 -€2,188 -20.9%
Stocks 30/36 €10,477 €8,290 -€2,188 -20.9%
Amounts receivable within one year 40/41 €56,604 €6,479 -€50,125 -88.6%
Trade receivables 40 €55,260 €1,144 -€54,116 -97.9%
Other amounts receivable 41 €1,344 €5,335 +€3,991 +297%
Cash at bank and in hand 54/58 €148,803 €75,508 -€73,295 -49.3%
Deferred charges and accrued income 490/1 €0 €2,813 +€2,813
Total equity and liabilities 10/49 €283,932 €127,922 -€156,010 -54.9%
Equity 10/15 €201,748 €91,996 -€109,752 -54.4%
Contributions 10/11 €19,500 €21,450 +€1,950 +10.0%
Reserves 13 €75,950 €70,546 -€5,404 -7.1%
Non-distributable reserves 130/1 €1,950 - -€1,950
Reserves not available under the articles 1311 €1,950 - -€1,950
Distributable reserves 133 €74,000 €70,546 -€3,454 -4.7%
Profit (loss) carried forward 14 €106,298 - -€106,298
Amounts payable 17/49 €82,184 €35,926 -€46,258 -56.3%
Amounts payable after more than one year 17 €31,141 €23,538 -€7,603 -24.4%
Financial debts 170/4 €31,141 €23,538 -€7,603 -24.4%
Amounts payable within one year 42/48 €50,954 €12,382 -€38,572 -75.7%
Current portion of amounts payable after more than one year 42 €7,377 €7,603 +€227 +3.1%
Trade debts 44 €39,042 €4,424 -€34,619 -88.7%
Suppliers 440/4 €39,042 €4,424 -€34,619 -88.7%
Taxes, remuneration and social security 45 €0 €147 +€147
Taxes 450/3 €0 €147 +€147
Other amounts payable 47/48 €4,535 €208 -€4,327 -95.4%
Accrued charges and deferred income 492/3 €89 €6 -€83 -93.4%
Turnover 70 €33,657 - -€33,657
Non-recurring operating income 76A €16,200 €14,269 -€1,931 -11.9%
Goods, raw materials, services and sundry goods 60/61 €50,583 - -€50,583
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,047 €9,235 +€188 +2.1%
Other operating charges 640/8 €1,178 €4,176 +€2,998 +255%
Non-recurring operating charges 66A - €27,867 +€27,867
Gross operating margin 9900 €1,277 €2,751 +€1,474 +115%
Operating profit (loss) 9901 -€8,948 -€38,527 -€29,580 -331%
Financial income 75/76B €174 €788 +€615 +354%
Recurring financial income 75 €174 €788 +€615 +354%
Financial charges 65/66B €2,088 €1,749 -€340 -16.3%
Recurring financial charges 65 €2,088 €1,749 -€340 -16.3%
Profit (loss) for the period before taxes 9903 -€10,862 -€39,488 -€28,626 -264%
Income taxes 67/77 €678 -€4,736 -€5,414
Profit (loss) for the period 9904 -€11,540 -€34,752 -€23,212 -201%
Profit (loss) for the period to be appropriated 9905 -€11,540 -€34,752 -€23,212 -201%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€91,996 to €91,996

Midpoint €91,996 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €91,996
Indication €91,996

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€91,996
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€91,996

Capitalised earnings

net result for the year (9904)
2025
-€34,752
excluding non-recurring income and charges
-€21,154
2024
-€11,540
excluding non-recurring income and charges
-€27,740
2023
-€23,122
2022
€49,362
2021
€25,574
Average result, excluding non-recurring income and charges
-€24,005
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.